Novo Nordisk files second round of lawsuits against compounding pharmacies hawking illegal semaglutide
Novo Nordisk is going after compounding pharmacies in federal court again, filing three lawsuits in Florida and one in Tennessee Thursday, accusing the companies of illegally marketing and selling drugs that they claim contain semaglutide.
The new lawsuits come on the heels of an initial five lawsuits Novo Nordisk filed two weeks ago and builds on its promise to continue to pursue illegal semaglutide compounders.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.